Source A nurse prepares the AstraZeneca Covid-19 vaccine in Deisenhofen, Germany, on March 31. A quick recap: After days of speculative media coverage, European drug regulators on Wednesday confirmed a possible link between the Oxford-AstraZeneca vaccine and rare blood clots, and UK authorities recommended that people under 30 should take alternative vaccines. While the European Medicines Agency and its British counterpart acknowledged that growing evidence pointed to a link, they both emphasized that the chances of clots were on balance still very low and that the vaccine was still very effective at preventing Covid-19. The EMA’s decision was based on 18 deaths in 62 cases of clotting in the sinuses that drain blood from the brain and 24 cases of clotting in the abdomen. […] The British government is already fighting back in the hope that Wednesday’s news won’t lead to vaccine hesitancy.
Click here to read the full article